Cargando…
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238649/ https://www.ncbi.nlm.nih.gov/pubmed/32434536 http://dx.doi.org/10.1186/s12943-020-01214-5 |
| _version_ | 1783536576191528960 |
|---|---|
| author | Xu, Ke Park, Dongkyoo Magis, Andrew T. Zhang, Jun Zhou, Wei Sica, Gabriel L. Ramalingam, Suresh S. Curran, Walter J. Deng, Xingming |
| author_facet | Xu, Ke Park, Dongkyoo Magis, Andrew T. Zhang, Jun Zhou, Wei Sica, Gabriel L. Ramalingam, Suresh S. Curran, Walter J. Deng, Xingming |
| author_sort | Xu, Ke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7238649 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72386492020-05-29 Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy Xu, Ke Park, Dongkyoo Magis, Andrew T. Zhang, Jun Zhou, Wei Sica, Gabriel L. Ramalingam, Suresh S. Curran, Walter J. Deng, Xingming Mol Cancer Correction BioMed Central 2020-05-20 /pmc/articles/PMC7238649/ /pubmed/32434536 http://dx.doi.org/10.1186/s12943-020-01214-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Xu, Ke Park, Dongkyoo Magis, Andrew T. Zhang, Jun Zhou, Wei Sica, Gabriel L. Ramalingam, Suresh S. Curran, Walter J. Deng, Xingming Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy |
| title | Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy |
| title_full | Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy |
| title_fullStr | Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy |
| title_full_unstemmed | Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy |
| title_short | Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy |
| title_sort | correction to: small molecule kras agonist for mutant kras cancer therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238649/ https://www.ncbi.nlm.nih.gov/pubmed/32434536 http://dx.doi.org/10.1186/s12943-020-01214-5 |
| work_keys_str_mv | AT xuke correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT parkdongkyoo correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT magisandrewt correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT zhangjun correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT zhouwei correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT sicagabriell correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT ramalingamsureshs correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT curranwalterj correctiontosmallmoleculekrasagonistformutantkrascancertherapy AT dengxingming correctiontosmallmoleculekrasagonistformutantkrascancertherapy |